Abstract. Apoptosis induction causes over-expression of the Na + /Ca 2+ exchanger of type 1 (NCX1) in the HeLa cell line. During induction of apoptosis and in the presence of isoproterenol hydrochloride (I; β-adrenergic agonist), increase in the NCX1 is even more pronounced. Anti-apoptotic Bcl-2 mRNA and protein is markedly reduced during apoptosis and in the presence of I, which causes a rapid increase in the Bax/Bcl-2 ratio. During apoptosis induction by apoptosis inducing kit (A), both with and without I, the active form of caspase-3, which is the executive enzyme in apoptosis, becomes visible on Western blots. Silencing NCX1 resulted in the reversal of the Bax/Bcl-2 ratio, it prevented a decrease in mitochondrial membrane potential compared to the AI group and it decreased the level of AI-induced apoptosis in HeLa cells. Based on the experiments with single apoptotic inducers camptothecin, cycloheximide and dexamethasone, it might be proposed that potentiated apoptotic effect in I-treated cells is due to the inhibition of nuclear topoisomerase. As illustrated in immunofluorescence and Western blot analysis, calnexin increased significantly during induction of the apoptosis in the presence of I. In addition, further decrease in sarco/endoplasmic ATPase 2 (SERCA2), decrease in reticular calcium and mitochondrial membrane potential was observed, which suggests development of the endoplasmic reticulum (ER) stress. Based on these results, we propose that I further enhanced NCX1 expression in apoptotic cells through the development of ER stress.
Isoproterenol accelerates apoptosis through the over-expression of the sodium/calcium exchanger in HeLa cells

Introduction
The Na + /Ca 2+ exchanger (NCX) has been shown to play an important role in the induction of apoptosis in many types of cells. Over-expression of the NCX is coupled to endoplasmic reticulum (ER) stress-related apoptosis in insulin-releasing cells (Diaz-Hortha et al. 2002) and also in hypoxia-induced apoptosis in HEK 293 cells (Hudecova et al. 2011 ). However, a major contribution of the NCX to apoptotic cell death was shown in cardiac tissue. Eigel and co-workers (2004) reported that type 1 NCX (NCX1) plays a critical role in the initiation of apoptosis after hypoxia-reoxygenation in ventricular myocytes and that hypoxia-reoxygenation-induced apoptosis is quite sensitive to changes in NCX activity (Eigel et al. 2004) . Myocardial tissue undergoing stress is β-adrenergic receptor (β-AR) stimulated and NCX1 is up-regulated at both, the transcriptional and protein levels (Hudecova et al. 2007; Mani et al. 2010; Singh et al. 2011 ). This up-regulation is a proximate cause in calcium oscillations and sustained intracellular Ca 2+ increase, inducing loss of mitochondrial membrane potential and subsequent apoptosis (Miyamoto et al. 2005) . It was shown, that a cAMP-protein kinase A (PKA) pathway is responsible for the β-adrenergic stimulation-induced apoptosis in cardiac myocytes (Iwai-Kanai et al. 1999) , and thereby this machinery stimulates Na + /Ca 2+ exchange (Barman et al. 2011 ). It appears that apoptotic pathways are related to the cell type and its physiological status, because activation of this same cAMP pathway almost completely inhibited apoptosis in the pheochromocytoma cell line (PC12, Barman et al. 2011) .
Cancer cells are known to be more resistant to apoptotic stimuli, mainly due to deregulation of apoptotic proteins. During early apoptosis, increased permeability of the mitochondrial outer membrane allows the release of pro-apoptotic factors, which promote and amplify the apoptotic cascade. Proteins of the Bcl-2 family are key regulators of this event (Hanahan and Weinberg 2000; Danial 2007) . In this family, effector proteins such as Bax are essential for the machinery enabling increased mitochondrial membrane permeability, and anti-apoptotic members such as Bcl-2 inhibit this process by directly binding to the pro-apoptotic effector proteins (Teijido and Dejean 2010) . It is well known that a large number of tumour cells have up-regulated anti-apoptotic Bcl-2 protein, which is a part of their enhanced survival strategy, and therefore Bcl-2 is frequently used as tumour marker (Fendri et al. 2011; Papageorgiou et al. 2011 . One of the main known functions ascribed to the Bcl-2 family of proteins at the ER is the control of calcium homeostasis. It is presumed that the balance between anti-and pro-apoptotic proteins at the ER has a direct effect on calcium content and release (Rodriguez et al. 2011) . Although it has been shown that Bcl-2 over-expressing cells have decreased ER calcium content (Oakes et al. 2006) , they simultaneously trigger calcium release to the same extent as Bcl-2-deficient cells which exhibit increased ER calcium content and increased calcium release from the ER following stimulation (Youle and Strasser 2008) . Bcl-2 over-expression prevents Ca 2+ -dependent apoptosis in dystrophic myotubes, and the beneficial effect of Bcl-2 over-expression is most likely mediated by direct Bcl-2-dependent IP 3 receptor inhibition (Basset et al. 2006) . β-adrenergic agonists play a role in carcinogenesis and tumour progression (Entschladen et al. 2005) . For example, leukaemia cell apoptosis induced by the β2 agonist -beta2Mim -correlated with an increase in calcium influx decreased Bcl-2 protein and mRNA levels, an increase in Bax gene expression and a marked rise in Bcl-2/Bax mRNA ratios (Mamani-Matsuda et al. 2004) . Increased Bcl-2 expression prevented apoptosis in the leukaemia cell, and it has been shown that long-acting β2-adrenergic agents promote apoptotic leukaemia cell death through an adrenoreceptor-and cAMP-independent, Ca 2+ -dependent mechanism (MamaniMatsuda et al. 2004) . In contrast, β-adrenergic antagonists can suppress invasion and proliferation by inhibiting both cAMP/PKA and Ras, which regulate the activation of the MAPK pathway and transcription factors, such as NFκB, AP-1 and CREB, and they also inhibit the expression of target genes (Zhang et al. 2010) . Alterations in calcium signalling and/or the expression of calcium pumps and channels are increasingly recognized abilities of some cancer cells. These also include changes in plasma membrane calcium ATPase (PMCA; Roberts-Thomson et al. 2010) or store-operated calcium channels (Wang et al. 2011) , but less information is available about the coupling of calcium transport systems with both β-adrenergic stimulation and apoptosis in cancer cells.
Therefore, the aim of this work is to couple the effects of β-adrenergic stimulation and the NCX1 during induction and early phase of the apoptosis in a HeLa-stable cell line.
Materials and Methods
Cells and drugs
A human cervix carcinoma cell line, HeLa, was grown in 6-wells plates in DMEM (Sigma Aldrich, USA) supplemented with 10% fetal bovine serum (FBS; Sigma Aldrich, USA) and a mixture of streptomycin and penicillin (both from Calbiochem, Merck Biosciences, Darmstadt, Germany) in the humidified atmosphere of 5% CO 2 air at 37°C. Cells were plated at a density of 1 × 10 5 , and drugs were applied for 24 hours as follows: apoptosis inducer kit (A; Calbiochem, Merck, Darmstadt, Germany) was diluted to 1:1000 as recommended by the producer. A is composed of the following inducers -Actinomycin D, Camptothecin, Cycloheximide, Dexamethasone, and Etoposide. Camptothecin (camp), Cycloheximid (cxi) and Dexamethasone were used also separately in dilution 1:1000. Isoproterenol hydrochloride (I; TOCRIS Bioscience, Ellisville, USA) was used in the final concentration of 10 µM.
Gene silencing
HeLa cells were grown in 6-well plates in DMEM with 10% FBS to 1 × 10 5 . Transfection of siRNAs was performed with DharmaFECT1 (Dharmacon, Thermo Scientific, USA) as described in (Hudecova et al. 2011 ). ON-TARGET plus siRNAs for human SLC81 (i.e. NCX1; Dharmacon, Thermo Scientific, USA) were applied to the final concentration of 25 pmol per well for 48 hours. The same procedure was performed with Non-Targeting plus siRNAs for scrambled control. Silencing was performed for 48 hours. After the first 24 hours, A and/or I were added to cells and incubated for a further 24 hours. These cells were then harvested and used in further experiments. 
Real Time PCR
Amplification and detection was performed by the ABI Prism 7900HT Sequence detection system (Applied Biosystems Inc., Foster City, CA, USA) with 10% of the reverse transcription product, 125 nM primers and SYBR Green Master Mix with ROX reference dye (Fermentas, Germany). The reaction was completed in a final volume of 20 µl in 96-well plates, which were centrifuged to remove air bubbles. Each sample was determined in duplicate, with one "no template" control. Cycles consisted of the initial denaturation step at 95°C for 10 min and initial activation for 2 min at 50°C. Each cycle included incubation for 15 s at 95°C, 30 s at 56-60°C and 30 s at 72°C. A routine melting curve analysis was performed following PCR completion to exclude nonspecific products. This was achieved by high resolution data collection during incremental temperature increases from 60 to 95°C. Data was analyzed by SDS software version 2.3 (Applied Biosystems Inc., Foster City, CA, USA). The copy number of the target genes was normalized to cyclophilin, as an unaffected endogenous reference.
Western blot analysis
Cells were scraped and pelleted at 1000 × g for 5 min. The pellet was then re-suspended in 10 mM Tris-HCl, pH 7.5, 1 mM phenylmethyl sulfonylfluoride (PMSF, Serva, Heidelberg, Germany), protease inhibitor cocktail tablets (complete EDTA-free, Roche Diagnostics, Mannheim, Germany) and subjected to centrifugation for 10 min at 3 000 × g and 4°C to remove cell debris. Proteins in the supernatant became soluble following incubation for 15 min at 4°C with 3-[(3-cholamidopropyl) dimethyl-ammonio] 1-propanesulfonate (CHAPS; Sigma, St. Louis, MO, USA) added to the final concentration of 50 mM. The protein concentration of lysate was determined by the Lowry method (Lowry et al. 1951 ). Ten to fifty micrograms of protein extract from each sample was separated by electrophoresis on 10-15% SDS -polyacrylamide gel, and proteins were transferred to the Hybond-P membrane using semi-dry blotting (Owl Inc., Portsmouth, NH). Membranes were blocked in 5% non-fat dry milk in Tris-buffered saline with Tween-20 (TBS-T), overnight at 4ºC and then incubated for 1 h with the appropriate primary antibody. Following washing, the membranes were incubated with secondary antibodies to mouse or rabbit IgG conjugated to horseradish peroxidase, for 1 h at room temperature. An enhanced chemiluminiscence detection system (ECL Plus, Amersham Biosciences, UK) was used to detect bound antibody. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) signal from each sample was used as a housekeeper and control protein for quantification. The optical density of individual bands was measured by the Kodak Image station 440 device and quantified using PCBAS 2.0 software.
Antibodies raised against the following proteins were used: Mouse monoclonal antibody to NCX1 (R3F1; Swant, Bellinzona, Switzerland) detects a 116 and 70 kDa protein. This is monoclonal antibody against the canine NCX that recognizes two neighboring but non-overlapping sequences of the hydrophilic region of the exchanger, connecting the putative transmembrane segments 5 and 6. Thus, two upper bands are splice variants of 116/112 kDa. For the bar diagram, both bands were evaluated. For caspase-3 staining, a rabbit anti-caspase-3 polyclonal antibody was used (Calbiochem, Darmstadt, Germany) which recognizes 32 kDa of latent form and 20 kDa of active form of caspase-3. Anti-SERCA2 mouse monoclonal antibody (Affinity Bioreagents, USA) binds to the 110 kDa protein. 
Detection of apoptosis with Annexin V-Fluos
HeLa cells were trypsinized, washed with phosphate-buffered saline (PBS) and pelleted at 1000 × g for 5 min. A cell pellet from each well was re-suspended in 100 μl of Annexin V-Fluos (Roche Diagnostics, Mannheim, Germany) labelling solution and incubated at room temperature for 20 min in the dark. The labelling solution included incubation buffer with 10mM HEPES/NaOH pH 7.4, 140 mM NaCl and 5 mM CaCl 2 , 2 μl of Annexin V-Fluos and 0.02 μg propidium iodide (Roche Diagnostics, USA). Following this incubation, the reaction was terminated by adding 300 μl ice-cold PBS, and products were measured in 96-well plates by the Accuri C6 flow cytometer (BD Accuri Cytometers Ann Arbor, MI, USA).
Cytofluorometric analysis of the mitochondrial membrane potential
Analysis of mitochondrial membrane potential via ψ m was performed as described in Jakubikova et al. (2005) . Briefly; cells were collected by centrifugation at 1000 × g for 5 min and washed twice with cold PBS. Incubation was performed in 200 µl of PBS/0.2% bovine serum albumine (BSA) containing 4 µM fluorescent dye 5,5' ,6,6'-tetrachloro-1,1' ,3,3'-tetraethylben-zimidazolyl-carbocyanine iodide (JC-1) and 7-aminoactinomycin D (7-AAD; 5 ng/µl; both from Invitrogen, Life Technologies, USA) for 30 min at 37°C in the dark. 7-AAD was used to exclude population of necrotic cells. Cell data was acquired using the Epics Altra (Beckman Coulter) flow cytometer equipped with 488 nm excitation laser and fluorescence emission of JC-1 green, JC-1 red; and 7-AAD was measured using a band pass filter set at 525, 575, and 675 nm, respectively. Forward and side light-scattering characteristics were used to exclude cell debris from the analysis. For each analysis, 1 × 10 4 cells were acquired, and the ratio of JC-1 red/JC-1 green fluorescence of viable cells (7-AAD negative) was used to calculate the decrease in ψ m . Data was analyzed by FCS4 software (De Novo Software, Los Angeles, CA, USA).
Immunofluorescence
Immunofluorescence was performed using the procedure described in Hudecova et al. (2011) . Briefly; HeLa cells were plated on poly-L-lysine (Sigma-Aldrich, St. Louis, MD, USA) coated (10 mg/ml) coverslips in Sarstedt 24-well plates in 1 ml of DMEM medium, with 10% of fetal bovine serum and a mixture of streptomycin and penicillin (both from Calbiochem, Merck Biosciences, Darmstadt, Germany). Cells were incubated in the humidified atmosphere of 5% CO 2 air at 37°C. Following these treatment procedures, the cells were fixed in ice-cold methanol. Non-specific binding was blocked by incubation with PBS containing 1% BSA (Merck Biosciences, Darmstadt, Germany) for 30 min at 37°C. The cells were then incubated with primary antibodies diluted to 1:1000 for 60 min at 37°C. We used primary mouse monoclonal antibody to NCX1 and rabbit polyclonal antibody to calnexin (Abcam, Cambridge, UK). The coverslips were washed in PBS and incubated with Alexa Fluor 594 Goat Anti Mouse IgG (H+L) secondary antibody (Life Technologies) and CFTM488 Goat Anti-Rabbit IgG (H+L) (Biotium, Hayward, CA, USA) secondary antibody for 60 min. at 37°C. Finally, the cells were mounted on slides in a mounting medium with Citifluor (Agar Scientific, Essex, UK), and analyzed by LSM 510 Meta microscope (Zeiss) with EC plan-Neofluar 40× objective. All images were produced by identical camera and microscope setup.
NCX activity in HeLa cells
NCX transport was measured as described in Hudecova et al. (2011) . Briefly: plated cells were washed for 3 min with hypotonic cell solution (0.1 mM MgCl 2 and 3 mM HEPES, pH 7.4). An isotonic cell solution was then added, with Fluo-3AM (Invitrogen, USA) and calcium (1 mM MgCl 2 , 10 mM HEPES (pH 7.4), 10 mM glucose, CaCl 2 to a final concentration of 500 µM, Fluo-3 AM to a final concentration of 8 µM and pluronic acid to 0.04%). After 20 min loading in the dark at room temperature, cells were washed with isotonic cell solution and a solution of 5 mM KCl or 140 mM NaCl was added. The fluorescence signal was measured by the fluorescence reader BioTec at 37°C. Excitation was measured at 485 nm and emission at 528 nm. Calcium transport was calculated from the difference in the fluorescent signal for the KCl and NaCl solutions. The control for the fluorescent signal was achieved by adding 10% SDS and 50 mM EGTA (pH 7.4) following the measurements. Calcium transport was expressed in arbitrary fluorescent units.
[Ca 2+ ]-free measurement in reticular fraction with fluorescent dye Rhod-5N
Cells were scraped from wells, sedimented and washed with 1 × PBS solution. Gentle lysis was performed with 100 µl of cell lysis buffer from the kit for cytoplasmic and nuclear protein isolation (ProteoJetTM, Fermentas, Germany) and dithiothreitol to a final concentration of 1 mM. Postmi-Na + /Ca 2+ exchanger, isoproterenol and apoptosis tochondrial fractions with endoplasmic cisternae were isolated as described in Pacak et al. (2012) . Pellets from the post-mitochondrial fraction were homogenized in nuclear lysis buffer from ProteoJet TM kit and pipetted to wells in a 24-well plate. Rhod-5N fluorescent dye (Invitrogen Ltd., Paisley, UK) was added to each sample to a final concentration of 20 μM. Measurements were performed by the BioTek fluorescent reader (excitation 551 nm/emission 576 nm). After measuring fluorescence (F), the signal was saturated by adding EGTA solution (pH 7.0) to a final concentration of 2.5 mM (F min 
Statistical analysis
Each value resulted from an average of 24-30 wells in at least 4 independent cultivations of HeLa cells. Results are presented as mean ± S.E.M. Statistical differences between the groups were determined by ANOVA. Statistical significance of p < 0.05 was considered as significant for * and ** p < 0.01, *** p < 0.001 compared to controls. Statistical significance of + p < 0.05, ++ p < 0.01 and +++ p < 0.0001 was considered to be significant compared to A-treated group. An adjusted t-test with p values corrected by the Bonferroni method was used for multiple comparisons (Instat, GraphPad Software).
Results
Gene expression of the NCX1 was increased approximately 3-times in HeLa cells after 24 hours treatment with apoptosis inducer kit (A; Fig. 1a ) and approximately 7-times in the cells treated with combination of A and I (AI; Fig.  1a ). Subsequently, this increase was followed by an elevation of protein signal of the NCX1 and also by the NCX transport activity (Fig. 1b, c) . Protein levels of the ER stress marker -calnexin -revealed rapid increase in group treated with A and I simultaneously (AI; Fig. 2c ). SERCA2 was decreased after 24 hours of treatment with A and also in the cells, where combination of A and I was applied (AI; Fig. 2b ). Combination of A and I also caused significant decrease in the reticular calcium content (Fig. 2a) . No significant change was observed in groups treated with I or A, which supports the proposal about development of the ER stress in cells treated with their combination (AI), whereas apoptosis inducer kit is acting through other pathways. In order to see if the ER stress induced by combination of the A and I can result in apoptosis, we amplified mRNA signals by RT-PCR method (Fig. 3a) and also determined proteins by Western blot analysis (Fig. 3b) , for pro-apoptotic marker Bax and anti-apoptotic marker Bcl-2. We have shown that in the cells treated with A, a significant increase of Bax signal was present and complementary to that, levels of Bcl-2 were decreased (Fig. 3a,b ) . Ratio of these two components of apoptotic pathway shows not only development of apoptosis in the cells treated with A, but also massive increase in the apoptotic signal in the HeLa . Over-expression of the NCX1 is (at least partially) associated with enhanced Na + /Ca 2+ transport activity (c). Each column represents an average of at least 5 independent cultivations. Significance compared to control group (Cont): * p < 0.05, ** p < 0.01, *** p < 0.001 and significance between A and AI: + p < 0.05, ++ p < 0.01, +++ p < 0.001. (Fig. 3c,d ). Bax/Bcl2 ratio was similar when calculated from mRNA or protein levels. The possible role of the NCX1 in this pathway was proven by gene silencing of the NCX1 mRNA. NCX1 mRNA was silenced to app. 20% of the original value (Fig.  4a) , as determined by the real-time PCR. When combination of the A and I was applied to cells with silenced NCX1, ratio of the Bax/Bcl-2 decreased to control levels (Fig. 4b) . In cells treated with scrambled control siRNA and subsequently with combination of A and I, this effect has not been observed. In order to prove the direct effect of NCX1 silencing on apoptosis, appearance of active caspase-3 (Fig. 5a ) binding of Annexin V-Fluos (Fig. 5b) and also drop in mitochondrial membrane potential (Fig.  5c ) was measured. Activation of caspase-3 plays a central role in the execution-phase of cell apoptosis. Western blot analysis shows that in control cells and cells treated with I, most of the caspase-3 is in the inactive form, whereas in the cells treated with A and combination of drugs, a band for active form occurs (Fig. 5a ). Apoptosis measured by Annexin V-Fluos revealed significant increase in the AI group compared to control and this increase was significantly abolished in AI group with silenced NCX1 (Fig. 5b ). An involvement of mitochondria in the mechanisms of apoptosis was determined from a ratio of red fluorescence of JC-1 aggregates and green fluorescence of JC-1 monomers. Aggregation of monomers is directly correlated to mitochondrial membrane potential ψ m and their breakdown in dying cells results in increase of green fluorescence. In upper part of Fig. 5c , typical result of red/green ratio, indicating depolarization of mitochondrial membranes could be seen for control (Cont), A treated cells without (A) and with isoproterenol (AI). Experiments with ψ m clearly showed that in the cells treated with A (A) increased percentage of cells with depolarized mitochondrial membrane compared to control cells (A; Fig. 5c ) and this increase was potentiated in cells treated with combination of A and isoproterenol ( Fig. 5c; AI) . Silencing of the NCX1 (AIsil) prevented changes in the mitochondrial membrane potential (ψ m ), whereas scrambled RNAs had no such pronounced effect (AIscr Fig. 5c ).
Since individual apoptotic inducers used in A act on different pathways, we used camptothecin (camp), cycloheximid (cxi) and dexamethasone (dex). After the treatment of these compounds with I we compared NCX1 mRNA levels (Table 1) and apoptosis via Annexin V-Fluos positive cells (Fig. 6) . Although all these compounds increased NCX1 . Effect of the NCX1 silencing on the Bax/Bcl-2 ratio in AI combination. To assess whether the increase in AI combination observed in the Bax/Bcl-2 ratio is due to NCX1 up-regulation, we silenced the NCX1 mRNA (AIsil). We observed rapid silencing of the NCX1 by both classical PCR (not shown) and real-time PCR (a). Subsequently, a decrease in Bax/Bcl-2 ratio was observed in the AIsil group, but not in the group where scrambled siRNA (AIscr) was used as a control (b). This proved the involvement of NCX1 up-regulation in the development of apoptosis in the AI group. Each column represents an average of at least five independent cultivations. Significance compared to the control group is * p < 0.05, ** p < 0.01, *** p < 0.001 and significance between AI and AIsil is +++ p < 0.001. mRNA, no significant difference was observed after dex and dexI groups (Table 1) . Thus, for apoptotic measurements we used camp and cxi. Significant difference in the number of . When the group of cells treated with A and the AI combination (AI) was silenced by the NCX1 siRNA, the band of activated caspase-3 disappeared, while in the group of AI cells treated with the scrambled siRNA, the active form of Caspase-3 was detected (not shown). These results correspond with the determination of the apoptotic process by Annexin V-Fluos (b), where apoptosis was significantly reduced in AI cells treated with silenced NCX1. The apoptotic changes induced depolarization in the mitochondrial membranes. The decrease in mitochondrial membrane potential was significantly changed in HeLa cells treated with A (c), and it was further potentiated in cells treated with a combination of A and isoproterenol (AI). Silencing NCX1 prevented changes in ψ m (AIsil). Cells treated with scrambled RNAs (AIscr) did not show the effect as AIsil, thus highlighting the specific effect of silencing on mitochondrial membrane potential. Significance compared to Cont: * p < 0.05, *** p < 0.001, and the significance compared to the AI group: +++ p < 0.001. apoptotic cells in I-treated group was observed in camp, but not in cxi (Fig. 6 ). Calnexin is a chaperone, which retains unfolded or unassembled N-linked glycoproteins in the ER. Therefore, this protein is commonly considered for a marker of ER stress. In order to show NCX1 and calnexin levels in the same cells, we performed double labeling with the NCX1 and calnexin antibodies (Fig. 7) . In A-treated cells (A) red signal of the NCX1 became more intensive compared to control, while no green calnexin signal was visible. In the cells treated with the combination of A and I (AI), both signals were pronounced. In cells, where the NCX1 was silenced and cells were treated with combination of the A and I, green calnexin signal disappeared (AIsil; Fig .7) . In HeLa cells, where the scrambled siRNA as a negative silencing control was used and cells were treated with combination of the A and I, both red NCX1 signal and green calnexin signal appeared (AIscr; Fig. 7 
Discussion
NCX is an important regulator of intracellular calcium homeostasis, described mainly in the cardiac cells (for review see Maier, 2012) . In these cells, NCX function is ultimately connected with the catecholamine pathway and thus with signaling through adrenergic receptors (Orchard and Brette 2009) . Nevertheless, function of the NCX in other tissues is still under elucidation. In pancreatic beta-cells overexpression of the exchanger increases Ca 2+ -dependent and Ca 2+ -independent beta-cell death by apoptosis, a phenomenon resulting from the depletion of ER Ca 2+ stores with subsequent activation of caspase-12 . Activation of the process of apoptosis might be of a special interest in cancer cells. However, little is known about the regulation and function of the NCX in cancer cells. In this work we have shown that in HeLa cells, induction of apoptosis increased gene expression of the NCX1, which results in the elevation of the NCX1 protein and activity, while I does not affect mRNA and protein levels of this transport system, but increased activity of the NCX. This would point to different regulatory sites of I and apoptosis induction on the NCX. Surprisingly, in the cells treated with A and I, increase in the NCX1 mRNA was much more pronounced compared to A-treated cells only. Mechanism of this increase is not known, nevertheless, experiments with NCX1 silencing in AI-treated cells clearly point to up-regulation of the gene expression.
Cytotoxicity of several compounds might be mediated by induction of the ER stress in various cancer cells (Caba et al. 2012; Chiu et al. 2012; Liu et al. 2012; Zha et al. 2012) . Induction of apoptosis through the ER stress is an accepted On the right side, typical cytometric plot from each group is shown. Results are displayed as mean ± S.E.M. and each column represents an average of three cultivations. Statistical significance compared to Cont: ** p < 0.01, *** p < 0.001, and the significance compared to the apoptotic group without I: +++ p < 0.001. phenomenon (Park et al. 2012) . ER is an organelle intimately involved in control of cell activities through calcium signaling as well as in posttranslational protein folding and maturation. Changes in calcium fluxes in ER are ultimately involved in this process. NCX is largely distributed close to the sarcoplasmic reticulum (SR)/endoplasmic reticulum (ER) Ca 2+ stores in smooth muscle (Lederer et al. 1990; Moore et al. 1993 ) and astrocytes (Juhaszova et al. 1996) . It was already shown that NCX1.7 overexpression increased apoptosis induced by ER Ca 2+-ATPase inhibitors cells (DiazHorta et al. 2002) . NCX1.7 overexpression depleted ER Ca 2+ stores, sensitized the cells to the calcium-independent proapoptotic signaling pathways, and reduced cell proliferation by approximately 40% cells . In this work we have shown that induction of apoptosis by mixture of proapoptotic agents (using A) resulted in overexpression of the NCX1 in HeLa cell line without causing ER stress. Nevertheless, addition of β1 and 2 -adrenergic agonist -isoproterenol -to the cells resulted in depletion of reticular calcium store and resulted in further increase in apoptosis. When individual components of A were used, increase in a number of apoptotic cells after I treatment compared to apoptosis only occurred with camptothecin. These results point to the proposal that potentiated apoptotic effect in isoproterenol-treated cells is due to the inhibition of nuclear topoisomerase. From these results it would be apparent that increase in NCX is associated with the increased apoptosis in cancer HeLa cells. However, there are some conflicting results published until now. Garcia-Prieto and coworkers (2012) described that natural product OSW-1, which exhibits a potent antitumour effect on leukemia cells, inhibited the sodium-calcium exchanger (NCX1) on the plasma membrane, leading to an increase in cytosolic Ca 2+ and a decrease in cytosolic Na + . On the other side, overexpression of the NCX1 increases β-cell programmed cell death (apoptosis) and reduces β-cell proliferation (Nguidjoe et al. 2011) . Also, NCX1.7 overexpression increased apoptosis induced by ER Ca 2+ -ATPase inhibitors in cells . One of the possible explanations of this discrepancy might be functional cell disunity, but also individual compounds used.
There is growing evidence that some cancer progression is closely associated with beta-adrenoreceptors. Nevertheless, modulation of adrenergic receptors in cancer causes conflicting results. Non-selective β-ARs agonist isoproterenol significantly increased cell proliferation via β-ARs in a dose-dependent manner, with concomitant activation of ERK/MAPK signal pathway in human pancreatic ductal adenocarcinomas cell line (Panc-1 cells). I increased expression level of phosphorylated ERK in Panc-1 cells. Furthermore, in vivo study showed that I enhanced xenograft tumor growth and this effect was suppressed by non-selective β-ARs antagonist (β-blocker), propranolol treatment ). In the rat glioma cell line noradrenaline and the beta-adrenoceptor agonist isoproterenol showed significant inhibition of the 1,2,5(OH)2D3-induced programmed cell death. The β-adrenoceptor antagonist propanolol reversed this inhibition, while the alpha-adrenoceptor antagonist yohimbin was devoid of any effect. This suggests that the efficiency of antiproliferative vitamin D-related therapies could be influenced by endogenous levels of noradrenaline (Canova et al. 1997) . On the other hand, Mamani-Matsuda and co-workers (Mamani-Matsuda et al. 2004) reported that β2-adrenergic agents promote apoptotic leukemia cell death through Ca 2+ -dependent mechanism. Furthermore, it was shown that cell death of thymocytes can be induced after stimulation of β-adrenergic receptor, or by addition of exogenous cAMP. Apoptotic cell death in both cases was observed with the appearance of terminal deoxynucleotidyl transferase-mediated UTP-end labeling reactivity and the activation of caspase-3 in S49 T cells (Gu et al. 2000) . Also, β-AR activation induces apoptosis in immature T lymphocytes via G(s)α and PKA (Yan et al. 2000) .
Our results support the pro-activatory effect of I on the apoptosis induction, however, mechanism is untill now not known. Based on the experiments with individual apoptotic inducers, especially camptothecin, we might propose that potentiated apoptotic effect in I-treated cells is due to the inhibition of nuclear topoisomerase. Nevertheless, this proposal remained to be verified. Differences of I effect might account for different types of cells used in the experiment and also different pro-apoptotic compounds.
